Chlorpromazine Combined with Cidofovir for Treatment of a Patient Suffering from Progressive Multifocal Leukoencephalopathy

Publisher： Karger

E-ISSN： 1423-0100|50|6|412-417

ISSN： 0300-5526

Source： Intervirology, Vol.50, Iss.6, 2008-01, pp. : 412-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of progressive multifocal leukoencephalopathy

By O'Brien M.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 3, 2013-03 ,pp. : 295-295

Oxford University Press

Access to resources Recommend Favorite

Progressive Multifocal Leukoencephalopathy in a Patient with X-linked Agammaglobulinemia

By Teramoto Takahide   Kaneko Hideo   Funato Michinori   Sawa Hirofumi   Nagashima Kazuo   Hirose Yoshinobu   Kondo Naomi  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 11-12, 2003-12 ,pp. : 910-911

Informa Healthcare

Access to resources Recommend Favorite

Progressive Multifocal Leukoencephalopathy in a HIV-Negative Patient with Small Lymphocytic Leukemia following Treatment with Rituximab

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

A benefit–risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy

By Walker Anna   Watson Crystal   Alexopoulos Stamatia T.   Deniz Baris   Arnold Ryan   Bates David  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 629-635

Informa Healthcare

Access to resources Recommend Favorite

Lipid‐specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 3, 2015-03 ,pp. : 447-457

John Wiley & Sons Inc

Access to resources Recommend Favorite